4//SEC Filing
Williams David Michael 4
Accession 0000310158-25-000012
CIK 0000310158other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 8:46 AM ET
Size
8.9 KB
Accession
0000310158-25-000012
Insider Transaction Report
Form 4
Williams David Michael
EVP,Chief Info&Digital Officer
Transactions
- Tax Payment
Common Stock
2025-08-04$79.29/sh−8,432$668,573→ 33,013.467 total - Exercise/Conversion
Restricted Stock Unit
2025-08-04−17,119→ 0 totalFrom: 2025-08-03Exp: 2025-08-03→ Common Stock (17,119 underlying) - Exercise/Conversion
Common Stock
2025-08-04$79.29/sh+17,119$1,357,366→ 41,445.467 total
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 8/4/2025, the business day immediately following 8/3/2025. The Reporting Person's Form 4 filed on 8/4/2022 incorrectly reported that these restricted stock units vested and were to be distributed in three equal installments on 8/3/2023, 8/3/2024, and 8/3/2025.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001820958
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 8:46 AM ET
- Size
- 8.9 KB